Skip to main content
logo
Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
30.06
+2.06 (7.36%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Damora Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,856376202977
Market Cap Growth
47073.27%500.17%-68.63%-33.64%-61.57%-75.78%
Enterprise Value
1,31531-14-24-46-50
Last Close Price
30.0623.014.6518.0028.7575.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.810.150.390.600.480.65
P/TBV Ratio
4.81-0.420.600.480.65

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-00.010.010.010.01
Net Debt / Equity Ratio
-1.05-1.07-0.89-1.02-1.06-0.92
Net Debt / EBITDA Ratio
5.617.050.840.911.072.08
Net Debt / FCF Ratio
12.1438.290.760.891.512.06
Quick Ratio
19.6512.8812.585.985.5522.55
Current Ratio
19.7312.9814.076.315.7524.23
Return on Equity (ROE)
-99.74%-163.80%-89.03%-81.52%-68.86%-36.61%
Return on Assets (ROA)
-21.61%-16.46%-38.15%-40.90%-39.15%-22.22%
Return on Capital Employed (ROCE)
-18.70%-15.20%-106.00%-112.50%-98.60%-44.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.00%-570.92%-350.08%-196.45%-209.48%-67.61%
FCF Yield
-2.40%-18.30%-304.10%-189.08%-146.60%-68.63%
Buyback Yield / Dilution
-1814.32%-17.79%-8.87%-4.58%-0.58%-452.45%
SEC Filings: 10-K · 10-Q